(Q35915662)

11 August 2017

1 reference

title

Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide (English)

1 reference

11 August 2017

0 references

K E Van Cott

1

1 reference

11 August 2017

P E Monahan

series ordinal

2

1 reference

11 August 2017

T C Nichols

series ordinal

3

1 reference

11 August 2017

W H Velander

series ordinal

4

1 reference

11 August 2017

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

10 Suppl 4

1 reference

11 August 2017

70-76

1 reference

Utilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS).

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Bioengineering of coagulation factor VIII for improved secretion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Hemophilia: treatment options in the twenty-first century

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

The overall effectiveness of prophylaxis in severe haemophilia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Biochemical characterization of recombinant factor IX.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

The manufacturing process for recombinant factor IX.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Minimization of viral contamination in human pharmaceuticals produced in the milk of transgenic goats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Blood proteins from transgenic animal bioreactors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Synthesis of vitamin K-dependent proteins

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

27 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

rFactor VIII deficit questioned

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Transgenic pigs produce functional human factor VIII in milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Recombinant antithrombin: production and role in cardiovascular disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

Oral treatment of haemophilia A by gastrointestinal absorption of factor VIII entrapped in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00983.X

A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Factor concentrate usage in persons with hemophilia in New York State

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925420

Biotech industry faces new bottleneck

24 September 2018

1 reference

12 December 2020

Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs

1 reference

12 December 2020

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

1 reference

12 December 2020

Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans

1 reference

12 December 2020

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

1 reference

12 December 2020

Structural analysis of N-linked sugar chains of human blood clotting factor IX

1 reference

12 December 2020

10.1111/J.1365-2516.2004.00983.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

15479375

1 reference